Skip to menu Skip to content Skip to footer
Professor Hemamali Samaratunga
Professor

Hemamali Samaratunga

Email: 

Overview

Background

Hemamali Samaratunga MBBS (Hons) LRCP (London) MRCS (UK) FRCPA, FRCPath

  • Specialist Anatomical Pathologist, Managing Director, Aquesta Specialised Uropathology
  • Full Professor, University of Queensland Faculty of Medicine
  • Visiting Medical Officer, Greenslopes Private Hospital

Hemamali graduated with honours from the University of Sri Lanka, Colombo Medical School and completed Pathology specialty training in Queensland. She held a number of consultant posts in both hospital and private practice. In 2008 she established Aquesta Uropathology which now provides diagnostic uropathology services to the majority of urologists in Queensland and Northern New South Wales. In addition to this she maintains a large second opinion consultation practice with requests obtained from throughout Australia and from overseas.

She is active in Genitourinary Pathology research with collaborators in Australia, USA, Canada, Karolinska Institute in Sweden and the Wellington School of Medicine in New Zealand. She held the position of Secretary of the International Society of Urological Pathology from 2015 to 2019.

She was a contributor to the 2004, 2015 and 2022 World Health Organization (WHO) books on Classification of Tumours: Pathology and Genetics of Tumours of the Urinary and Male Reproductive System. She participated in the 2015 revision of the WHO Tumour Classification in Zurich, Switzerland (4th edition) as member, Prostate Tumour Panel. She was a representative of the Expert Groups formulating structured reporting protocols for the Royal College Pathologists of Australasia on kidney, testis and prostate cancer and is currently chairperson of the structured reporting protocols for Genitourinary cancer. She is also currently the Convener for the RCPA Uropathology Quality Assurance Program.

Qualifications

MBBS (HONS) LRCP (London) MRCS (UK) FRCPA FRCPath

Current UQ Appointments

Academic Title-Professor

Non-UQ Appointments

2008 - current: Specialist Anatomical Pathologist & Managing Director, Aquesta Specialized Uropathology

2015 - Current: Visiting Medical Officer, Greenslopes Private Hospital

2003 - 2021: Visiting Medical Officer, Princess Alexandra Hospital

June 2001 - Oct 2008: Specialist Anatomical Pathologist, Sullivan Nicolaides Pathology, Brisbane

1993 - 1997: Specialist Anatomical Pathologist, Royal Brisbane Hospital

1998 - 2001: Senior Anatomical Pathologist, North Brisbane Hospitals Board

Research Interests

  • Granular tumour necrosis
  • Diagnosis of limited adenocarcinoma on prostate needle biopsy
  • Ductal adenocarcinoma of prostate
  • Mucinous adenocarcinoma of prostate
  • Radical prostatectomy handling and reporting
  • Micropapillary urothelial cancer
  • Mimics of bladder cancer

Awards and other Esteem Indicators

2017 Admitted to Fellowship of the Royal College of Pathologists, London (FRC Path) for sustained excellence in published works

2022 Awarded the Grawitz Medal of the International Society of Urological Pathology for distinguished service to the discipline of Urological Pathology

2023 Author of the publication Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: Ten year data from the TROG 03.04 RADAR Trial. Pathology 54: 49- 54, awarded the prize of

Article of the Year by the Royal College of Pathologists of Australasia.

2024 Distinguished Fellowship Award of the Royal College Pathologists of Australasia

For distinguished service to the discipline of Urological Pathology

Keywords

Pathology, Genitourinary cancer, Prostate, Kidney, Urinary tract, Testis, Penis

Availability

Professor Hemamali Samaratunga is:
Available for supervision

Research impacts

She has over 320 scientific publications and has a Google Scholar H-index of 56 with 18150 citations. To date she has authored or co-authored 28 books, 21 book chapters and 274 peer-reviewed publications. Apart from her primary research activities Professor Samaratunga actively collaborates with other research groups and is a regular contributor - often as primary or senior author to international research consortia. One notable contribution has been her involvement in the development of artificial intelligence programs for the reporting of prostate cancer. In collaborative studies involving colleagues from the Netherlands, Sweden, Australia, New Zealand and the United States she was chosen to be one of three expert pathologists to review all cases, thus setting the gold standard for the diagnosis and grading of prostate cancer. These studies have been published in highly prestigious journals as noted in her CV. Importantly in comparative studies, the AI program informed by the findings of group of three pathologists that included Professor Samaratunga, outperformed all other AI programs.

Works

Search Professor Hemamali Samaratunga’s works on UQ eSpace

305 works between 1988 and 2025

41 - 60 of 305 works

2022

Journal Article

Re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019

Samaratunga, Hemamali, Delahunt, Brett and Egevad, Lars (2022). Re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019. European Urology, 82 (1), e15-e16. doi: 10.1016/j.eururo.2022.03.032

Re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019

2022

Journal Article

Prognostic significance of percentage Gleason grade 5 prostatic adenocarcinoma in needle biopsies from patients treated by radical prostatectomy

Yaxley, William, Delahunt, Brett, Yaxley, John, Thunders, Michelle C., Kenwright, Diane N., Egevad, Lars and Samaratunga, Hemamali (2022). Prognostic significance of percentage Gleason grade 5 prostatic adenocarcinoma in needle biopsies from patients treated by radical prostatectomy. Pathology, 54 (6), 694-699. doi: 10.1016/j.pathol.2022.02.009

Prognostic significance of percentage Gleason grade 5 prostatic adenocarcinoma in needle biopsies from patients treated by radical prostatectomy

2022

Journal Article

Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy

Roberts, Matthew J., Morton, Andrew, Papa, Nathan, Franklin, Anthony, Raveenthiran, Sheliyan, Yaxley, William J., Coughlin, Geoffrey, Gianduzzo, Troy, Kua, Boon, McEwan, Louise, Wong, David, Delahunt, Brett, Egevad, Lars, Samaratunga, Hemamali, Brown, Nicholas, Parkinson, Robert, Emmett, Louise and Yaxley, John W. (2022). Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy. European Journal of Nuclear Medicine and Molecular Imaging, 49 (9), 3289-3294. doi: 10.1007/s00259-022-05756-2

Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy

2022

Journal Article

Findings in 1,123 men with preoperative 68Ga-prostate-specific membrane antigen positron emission tomography/computerized tomography and multiparametric magnetic resonance imaging compared to totally embedded radical prostatectomy histopathology: Implications for the diagnosis and management of prostate cancer

Raveenthiran, S., Yaxley, W. J., Franklin, T., Coughlin, G., Roberts, M., Gianduzzo, T., Kua, B., Samaratunga, H., Delahunt, B., Egevad, L., Wong, D., McEwan, L., Brown, N., Parkinson, R., Esler, R. and Yaxley, J. W. (2022). Findings in 1,123 men with preoperative 68Ga-prostate-specific membrane antigen positron emission tomography/computerized tomography and multiparametric magnetic resonance imaging compared to totally embedded radical prostatectomy histopathology: Implications for the diagnosis and management of prostate cancer. Journal of Urology, 207 (3), 573-580. doi: 10.1097/JU.0000000000002293

Findings in 1,123 men with preoperative 68Ga-prostate-specific membrane antigen positron emission tomography/computerized tomography and multiparametric magnetic resonance imaging compared to totally embedded radical prostatectomy histopathology: Implications for the diagnosis and management of prostate cancer

2022

Journal Article

International Society of Urological Pathology expert opinion on grading of urothelial carcinoma

van der Kwast, Theo, Liedberg, Fredrik, Black, Peter C., Kamat, Ashish, van Rhijn, Bas W. G., Algaba, Ferran, Berman, David M., Hartmann, Arndt, Lopez-Beltran, Antonio, Samaratunga, Hemamali, Varma, Murali and Cheng, Liang (2022). International Society of Urological Pathology expert opinion on grading of urothelial carcinoma. European Urology Focus, 8 (2), 438-446. doi: 10.1016/j.euf.2021.03.017

International Society of Urological Pathology expert opinion on grading of urothelial carcinoma

2022

Journal Article

Ductal and acinar components of mixed prostatic adenocarcinoma frequently have a common clonal origin

Lindh, Claes, Samaratunga, Hemamali, Delahunt, Brett, Bergström, Rebecka, Chellappa, Venkatesh, Yaxley, John, Lindberg, Johan and Egevad, Lars (2022). Ductal and acinar components of mixed prostatic adenocarcinoma frequently have a common clonal origin. The Prostate, 82 (5), 576-583. doi: 10.1002/pros.24304

Ductal and acinar components of mixed prostatic adenocarcinoma frequently have a common clonal origin

2022

Journal Article

Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge

Bulten, Wouter, Kartasalo, Kimmo, Chen, Po-Hsuan Cameron, Ström, Peter, Pinckaers, Hans, Nagpal, Kunal, Cai, Yuannan, Steiner, David F., van Boven, Hester, Vink, Robert, Hulsbergen-van de Kaa, Christina, van der Laak, Jeroen, Amin, Mahul B., Evans, Andrew J., van der Kwast, Theodorus, Allan, Robert, Humphrey, Peter A., Grönberg, Henrik, Samaratunga, Hemamali, Delahunt, Brett, Tsuzuki, Toyonori, Häkkinen, Tomi, Egevad, Lars, Demkin, Maggie, Dane, Sohier, Tan, Fraser, Valkonen, Masi, Corrado, Greg S., Peng, Lily ... Park, Jeonghyuk (2022). Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge. Nature Medicine, 28 (1), 154-163. doi: 10.1038/s41591-021-01620-2

Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge

2022

Journal Article

Detection of perineural invasion in prostate needle biopsies with deep neural networks

Kartasalo, Kimmo, Ström, Peter, Ruusuvuori, Pekka, Samaratunga, Hemamali, Delahunt, Brett, Tsuzuki, Toyonori, Eklund, Martin and Egevad, Lars (2022). Detection of perineural invasion in prostate needle biopsies with deep neural networks. Virchows Archiv, 481 (1), 73-82. doi: 10.1007/s00428-022-03326-3

Detection of perineural invasion in prostate needle biopsies with deep neural networks

2021

Journal Article

Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trial

Delahunt, B., Steigler, A., Atkinson, C., Christie, D., Duchesne, G., Egevad, L., Joseph, D., Kenwright, D.N., Matthews, J., Murray, J.D., Oldmeadow, C., Samaratunga, H., Spry, N.A., Thunders, M.C., Hondermarck, H. and Denham, J.W. (2021). Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trial. Pathology, 54 (1), 49-54. doi: 10.1016/j.pathol.2021.11.004

Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trial

2021

Journal Article

Lichen sclerosus presenting as an isolated bulbar urethral stricture

Attia, Arsany, Morton, Andrew, Raveenthiran, Sheliyan, Samaratunga, Hemamali and Desai, Devang (2021). Lichen sclerosus presenting as an isolated bulbar urethral stricture. Urology Case Reports, 39 101794, 101794. doi: 10.1016/j.eucr.2021.101794

Lichen sclerosus presenting as an isolated bulbar urethral stricture

2021

Journal Article

Intraductal carcinoma of the prostate: extreme nuclear size is not a diagnostic parameter

Samaratunga, Hemamali, Delahunt, Brett, Yaxley, John W., Johannsen, Shulammite and Egevad, Lars (2021). Intraductal carcinoma of the prostate: extreme nuclear size is not a diagnostic parameter. American Journal of Surgical Pathology, 45 (11), 1527-1533. doi: 10.1097/PAS.0000000000001776

Intraductal carcinoma of the prostate: extreme nuclear size is not a diagnostic parameter

2021

Journal Article

ISUP consensus definition of cribriform pattern prostate cancer

van der Kwast, Theodorus H., van Leenders, Geert J., Berney, Daniel M., Delahunt, Brett, Evans, Andrew J., Iczkowski, Kenneth A., McKenney, Jesse K., Ro, Jae Y., Samaratunga, Hemamali, Srigley, John R., Tsuzuki, Toyo, Varma, Murali, Wheeler, Thomas M. and Egevad, Lars (2021). ISUP consensus definition of cribriform pattern prostate cancer. American Journal of Surgical Pathology, 45 (8), 1118-1126. doi: 10.1097/PAS.0000000000001728

ISUP consensus definition of cribriform pattern prostate cancer

2021

Journal Article

The emerging role of artificial intelligence in the reporting of prostate pathology

Egevad, Lars, Delahunt, Brett, Samaratunga, Hemamali, Tsuzuki, Toyonori, Yamamoto, Yoichiro, Yaxley, John, Ruusuvuori, Pekka, Kartasalo, Kimmo and Eklund, Martin (2021). The emerging role of artificial intelligence in the reporting of prostate pathology. Pathology, 53 (5), 565-567. doi: 10.1016/j.pathol.2021.04.002

The emerging role of artificial intelligence in the reporting of prostate pathology

2021

Journal Article

Interobserver reproducibility of perineural invasion of prostatic adenocarcinoma in needle biopsies

Egevad, Lars, Delahunt, Brett, Samaratunga, Hemamali, Tsuzuki, Toyonori, Olsson, Henrik, Ström, Peter, Lindskog, Cecilia, Häkkinen, Tomi, Kartasalo, Kimmo, Eklund, Martin and Ruusuvuori, Pekka (2021). Interobserver reproducibility of perineural invasion of prostatic adenocarcinoma in needle biopsies. Virchows Archiv, 478 (6), 1109-1116. doi: 10.1007/s00428-021-03039-z

Interobserver reproducibility of perineural invasion of prostatic adenocarcinoma in needle biopsies

2021

Journal Article

Cribriform prostate cancer: Morphologic criteria enabling a diagnosis, based on survey of experts

Iczkowski, Kenneth A., van Leenders, Geert J.L.H., Tarima, Sergey, Wu, Ruizhe, Van der Kwast, Theodorus, Berney, Daniel M., Evans, Andrew J., Wheeler, Thomas M., Ro, Jae Y., Samaratunga, Hemamali, Delahunt, Brett, Srigley, John, Varma, Murali, Tsuzuki, Toyonori and Egevad, Lars (2021). Cribriform prostate cancer: Morphologic criteria enabling a diagnosis, based on survey of experts. Annals of Diagnostic Pathology, 52 151733, 1-5. doi: 10.1016/j.anndiagpath.2021.151733

Cribriform prostate cancer: Morphologic criteria enabling a diagnosis, based on survey of experts

2021

Journal Article

Re: Svetlana Avulova, John C. Cheville, Christine M. Lohse, et al. Grading of chromophobe renal cell carcinoma: evidence for a four-tiered classification incorporating coagulative tumor necrosis. Eur Urol 2021;79:225–31: Should chromophobe renal cell carcinoma Be graded?

Delahunt, Brett, Samaratunga, Hemamali and Egevad, Lars (2021). Re: Svetlana Avulova, John C. Cheville, Christine M. Lohse, et al. Grading of chromophobe renal cell carcinoma: evidence for a four-tiered classification incorporating coagulative tumor necrosis. Eur Urol 2021;79:225–31: Should chromophobe renal cell carcinoma Be graded?. European Urology, 79 (5), e141-e142. doi: 10.1016/j.eururo.2021.02.003

Re: Svetlana Avulova, John C. Cheville, Christine M. Lohse, et al. Grading of chromophobe renal cell carcinoma: evidence for a four-tiered classification incorporating coagulative tumor necrosis. Eur Urol 2021;79:225–31: Should chromophobe renal cell carcinoma Be graded?

2021

Journal Article

Prostate cancer grading, time to go back to the future

Egevad, Lars, Delahunt, Brett, Bostwick, David G., Cheng, Liang, Evans, Andrew J., Gianduzzo, Troy, Graefen, Markus, Hugosson, Jonas, Kench, James G., Leite, Katia R.M., Oxley, Jon, Sauter, Guido, Srigley, John R., Stattin, Pär, Tsuzuki, Toyonori, Yaxley, John and Samaratunga, Hemamali (2021). Prostate cancer grading, time to go back to the future. BJU International, 127 (2), 165-168. doi: 10.1111/bju.15298

Prostate cancer grading, time to go back to the future

2021

Journal Article

Prognostic significance of morphological patterns of Gleason grade 5 prostatic adenocarcinoma diagnosed on needle biopsy

Franklin, Anthony, Delahunt, Brett, Egevad, Lars, Yaxley, John, Johannsen, Shulammite, Gianduzzo, Troy, Ganter, Jonathan, Pecoraro, Carla, Thunders, Michelle and Samaratunga, Hemamali (2021). Prognostic significance of morphological patterns of Gleason grade 5 prostatic adenocarcinoma diagnosed on needle biopsy. Pathology, 53 (2), 199-204. doi: 10.1016/j.pathol.2020.10.009

Prognostic significance of morphological patterns of Gleason grade 5 prostatic adenocarcinoma diagnosed on needle biopsy

2021

Journal Article

Diagnostic approach in TFE3-rearranged renal cell carcinoma: a multi-institutional international survey

Akgul, Mahmut, Williamson, Sean R, Ertoy, Dilek, Argani, Pedram, Gupta, Sounak, Caliò, Anna, Reuter, Victor, Tickoo, Satish, Al-Ahmadie, Hikmat A, Netto, George J, Hes, Ondrej, Hirsch, Michelle S, Delahunt, Brett, Mehra, Rohit, Skala, Stephanie, Osunkoya, Adeboye O, Harik, Lara, Rao, Priya, Sangoi, Ankur R, Nourieh, Maya, Zynger, Debra L, Smith, Steven Cristopher, Nazeer, Tipu, Gumuskaya, Berrak, Kulac, Ibrahim, Khani, Francesca, Tretiakova, Maria S, Vakar-Lopez, Funda, Barkan, Guliz ... Idrees, Muhammad T (2021). Diagnostic approach in TFE3-rearranged renal cell carcinoma: a multi-institutional international survey. Journal of Clinical Pathology, 74 (5), 291-299. doi: 10.1136/jclinpath-2020-207372

Diagnostic approach in TFE3-rearranged renal cell carcinoma: a multi-institutional international survey

2021

Journal Article

External validation and addition of prostate-specific membrane antigen positron emission tomography to the most frequently used nomograms for the prediction of pelvic lymph-node metastases: an international multicenter study

Meijer, Dennie, van Leeuwen, Pim J., Roberts, Matthew J., Siriwardana, Amila R., Morton, Andrew, Yaxley, John W., Samaratunga, Hemamali, Emmett, Louise, van de Ven, Peter M., van der Poel, Henk G., Donswijk, Maarten L., Boellaard, Thierry N., Schoots, Ivo G., Oprea-Lager, Daniela E., Coughlin, Geoffrey D. and Vis, André N. (2021). External validation and addition of prostate-specific membrane antigen positron emission tomography to the most frequently used nomograms for the prediction of pelvic lymph-node metastases: an international multicenter study. European Urology, 80 (2), 234-242. doi: 10.1016/j.eururo.2021.05.006

External validation and addition of prostate-specific membrane antigen positron emission tomography to the most frequently used nomograms for the prediction of pelvic lymph-node metastases: an international multicenter study

Funding

Past funding

  • 2018 - 2022
    Utilisation of fresh human kidney tissue for research into kidney disease
    Metro South Hospital and Health Service
    Open grant
  • 2010 - 2011
    Towards Concurrent Imaging of Primary & Secondary Prostate Cancers
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2009 - 2010
    Molecular strategies for staging prostate cancer
    Cancer Council Queensland
    Open grant
  • 2005 - 2007
    Multiple Molecular Markers for Prostate Cancer Diagnosis from Enriched Cells from Ejaculate
    Queensland Cancer Fund
    Open grant

Supervision

Availability

Professor Hemamali Samaratunga is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Media

Enquiries

For media enquiries about Professor Hemamali Samaratunga's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au